Gyre Therapeutics
GYRE
GYRE
35 hedge funds and large institutions have $3.9M invested in Gyre Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
73% less capital invested
Capital invested by funds: $14.2M → $3.9M (-$10.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
35
Holding in Top 10
–
Calls
$1.3M
Puts
$2K
Top Buyers
| 1 | +$281K | |
| 2 | +$153K | |
| 3 | +$67.9K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$24K |
| 5 |
Lazard Asset Management
New York
|
+$23K |
Top Sellers
| 1 | -$1.79M | |
| 2 | -$140K | |
| 3 | -$101K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$45K |
| 5 |
BDF
Black Diamond Financial
Towson,
Maryland
|
-$32K |